<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of the respiratory stimulant, doxapram, on white matter damage was investigated in neonatal rats under <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Five-day-old rats underwent bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> with or without 50 mg/kg i.p. of doxapram </plain></SENT>
<SENT sid="2" pm="."><plain>Their brains were neuropathologically examined 48 h later </plain></SENT>
<SENT sid="3" pm="."><plain>Doxapram induced about a 20% decrease of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCO</z:e>(2) for 90 min, but did not cause any neuropathological abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>Bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in mild cerebrocortical lesions in 67% of pups, and white matter lesions in the internal capsule in 44% </plain></SENT>
<SENT sid="5" pm="."><plain>Doxapram, in addition to bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>, produced more severe white matter injury in the internal capsule (injury score; 0.67+/-0.87 vs. 1.70+/-0.48, P&lt;0.05) and in the subcortical white matter (0.33+/-0 </plain></SENT>
<SENT sid="6" pm="."><plain>67 vs. 1.10+/-0.54, P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>These results demonstrated that the use of doxapram under an ischemic condition accentuates white matter damage in neonatal rats </plain></SENT>
</text></document>